GH1 and Central hypothyroidism: Clinical management guidelines recommend long-term follow-up given reports of evolving central hypothyroidism [14], subclinical GH deficiency (paradoxical “growth without GH”) [10], and the association of untreated hypopituitarism with developmental delay and even death [12-15].